tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market
IBRX
ImmunityBio
RESEARCH TOOLSreports
Want to see IBRX full AI Analyst Report?

ImmunityBio (IBRX) Stock News & Sentiment

2,418 Followers
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
Premium
Company Announcements
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
7d ago
IBRX
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
Premium
Class Action
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
20d ago
IBRX
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
Premium
Company Announcements
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
30d ago
8K
IBRX
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
Premium
Weekend Updates
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
1M ago
AFL
MCO
ImmunityBio Bolsters Balance Sheet With New Financing Moves
Premium
Company Announcements
ImmunityBio Bolsters Balance Sheet With New Financing Moves
1M ago
8K
IBRX
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
Premium
Class Action
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky
1M ago
IBRX
ImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
Premium
Class Action
ImmunityBio Faces Securities Lawsuit Over Alleged Misleading Statements About Cancer Drug Anktiva
1M ago
IBRX
More IBRX News >

IBRX News on the Web

Cramer's lightning round: Buy Vertex Pharmaceuticals
CNBC
Neutral
ImmunityBio Stock Surges Back After Regulatory Scare
TipRanks News
Bullish
ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
TipRanks News
Bearish
Why ImmunityBio Stock Is Tumbling Despite Record Sales
TipRanks News
Bearish
ImmunityBio Stock Surges as Revenue Momentum Ignites
TipRanks News
Neutral
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
Zacks
Bullish
Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)
TipRanks News
Neutral
ImmunityBio Stock Jumps on Expanding Cancer Drug Reach
TipRanks News
Bullish

News Score - Last 7 Days

Negative
IBRX
Sector Average
Media Buzz
This Week5 articles
Weekly Average13.25 articles
News Sentiment
This Week33%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IBRX’s Media Buzz Sentiment?
5 articles about IBRX were published this week. In an average week, 13.25 articles are published.
    What is IBRX’s weekly average amount of articles?
    In an average week, 13.25 articles about IBRX are published.
      What is IBRX’s News Sentiment?
      33% of articles about IBRX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week